logo-loader

Tissue Regenix Group PLC

Receive alerts
Market:
AIM
Market Cap:
£37.5 m
Price
3.20 GBX
Change
0.00%
52 weeks high
9.00
52 weeks low
3.01

In brief

TISSUE REGENIX GROUP is a pioneering, international medical technology company, focusing on the development of regenerative products utilising our two platform technologies, dCELL®, addressing soft tissue needs, and BioRinseTM, providing inductive bone allografts.

We are helping to transform the treatment of patients in three key areas: BioSurgery, Orthopaedics & Dental and Cardiac.